Mid-day market update: Crude oil rises over 1%, Orphazyme shares plunge

Midway through trading Friday, the Dow traded down 1.13% to 33,440.28 while the NASDAQ fell 0.74% to 14,056.31. The S&P also fell, dropping 0.92% to 4,183.07.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,508,900 cases with around 600,930 deaths. India confirmed a total of at least 29,762,790 cases and 383,490 deaths, while Brazil reported over 17,702,630 COVID-19 cases with 496,000 deaths. In total, there were at least 177,465,600 cases of COVID-19 worldwide with more than 3,843,090 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer discretionary shares slipped by just 0.4% on Friday. Meanwhile, top gainers in the sector included Afya Limited AFYA 1.99%, up 1%, and Afya Limited ABNB 0.71%, up 1%.

In trading on Friday, financial shares tumbled 1.9%.

Top Headline

Adobe Inc ADBE 1.83% reported upbeat results for its second quarter and issued strong guidance for the current quarter on Thursday.

Adobe reported quarterly earnings of $3.03 per share, exceeding analysts’ estimates of $2.81 per share. The company’s quarterly sales came in at $3.84 billion, topping expectations of $3.73 billion.

Adobe said it sees Q3 adjusted earnings of $3.00 per share, versus analysts’ estimates of $2.89 per share. The company projects sales of $3.88 billion, compared to expectations of $3.83 billion.

Equities Trading UP

CAI International, Inc. CAI 45.95% shares shot up 46% to $55.90 after the company agreed to be acquired by Mitsubishi HC Capital for $56 per share in cash.

Shares of Sykes Enterprises, Incorporated SYKE 29.74% got a boost, shooting 30% to $53.48 after the company announced it will be acquired by Sitel Group at a purchase price of $54 per share in cash.

Geron Corporation GERN 28.72% shares were also up, gaining 34% to $1.8962 after the company reported the publication of IMbark Phase 2 data in the Journal of Clinical Oncology.

Equities Trading DOWN

Athira Pharma, Inc. ATHA 37.37% shares tumbled 38% to $11.27. Athira Pharma’s CEO Leen Kawas has been placed on temporary leave until the company completes a review “stemming from doctoral research Dr. Kawas conducted while at Washington State University.” The company, which is developing drugs for treating Alzheimer’s disease, said that Chief Operating Officer Mark Litton would assume day-to-day responsibilities during Kawas’ leave.

Shares of Orphazyme A/S ORPH 49.52% were down 43% to $8.35 after the company announced it received a Complete Response Letter from the FDA for its treatment for Niemann-Pick Disease Type C and also cut its FY2021 outlook

Capstone Green Energy Corporation CGRN 22.13% was down, falling 22% to $5.71 after the company increased its earlier announced bought deal offering of common stock to $10.0 million.


In commodity news, oil traded up 1.3% to $71.96, while gold traded up 0.1% to $1,777.10.

Silver traded up 0.9% Friday to $26.10 while copper fell 0.5% to $4.1560.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 1.6%, the Spanish Ibex Index fell 2% and the German DAX 30 fell 1.9%. Meanwhile, the London’s FTSE 100 fell 2%, French CAC 40 fell 1.5% and Italy’s FTSE MIB fell 1.8%.

Producer prices in Germany surged 7.2% year-over-year in May, recording the strongest growth since October 2008. UK’s retail sales fell 1.4% in May versus a 9.2% rise in April, while construction output in Italy rose 60.2% year-over-year in April. The Eurozone current account surplus increased to EUR 31.4 billion in April from EUR 12.1 billion in the year-ago month.


The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.

Benzinga does not provide investment advice. All rights reserved.

Feed news

Latest Forex Analysis

Latest Forex Analysis

Editors’ Picks

EUR/USD refreshes daily high above 1.1850 ahead of EU data

EUR/USD is trading above 1.1850, as it continues to notch higher on Thursday. Dovish Fed downs the US Treasury yields alongside the US dollar. Rebound in Chinese stocks lifts overall market mood, weighing further on the safe-haven dollar. Eurozone data and US GDP in focus.


GBP/USD renews monthly top above 1.3900 on softer USD, Brexit optimism

GBP/USD picks up bids to refresh multi-day high above 1.3900. US dollar tracks Treasury yields to the south amid Fed’s dovish tilt. EU softens legal threat over NI protocol on demand of UK’s Frost. UK scraps quarantine rules for fully vaccinated EU, US travelers.


Gold remains on track to test 200-DMA, US GDP awaited

In the aftermath of the Fed decision, gold price is extending its recent run higher, looking to recapture the critical 200-Daily Moving Average (DMA) at $1821. The market mood has improved amid a rebound in the Chinese stocks.

Gold News

SafeMoon Price Prediction: SAFEMOON contemplates 34% gains

SafeMoon price is experiencing a bottom formation as SAFEMOON approaches a crucial support level twice over the past week. If a bounce from this barrier evolves, it will indicate a double bottom reversal in play. SafeMoon price crashed 20% between July 19 and July 20 to $0.00000273.

Read more

US Q2 GDP Preview: Economy to continue to expand at strong pace

The US Bureau of Economic Analysis (BEA) will release on Thursday, July 29, its first estimate of the annualized Gross Domestic Product (GDP) growth for the second quarter. 

Read more